The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Representing uncertainty: the role of cost‐effectiveness acceptability curves
Abstract
Decision‐making in health care is inevitably undertaken in a context of uncertainty concerning the effectiveness and costs of health care interventions and programmes. One method that has been suggested to represent this uncertainty is the cost‐effectiveness acceptability curve. This technique, which directly addresses the decision‐making problem, has advantages over confidence interval estimation for incremental cost‐effectiveness ratios. However, despite these advantages, cost‐effectiveness acceptability curves have yet to be widely adopted within the field of economic evaluation of health care technologies. In this paper we consider the relationship between cost‐effectiveness acceptability curves and decision‐making in health care, suggest the introduction of a new concept more relevant to decision‐making, that of the cost‐effectiveness frontier, and clarify the use of these techniques when considering decisions involving multiple interventions. We hope that as a result we can encourage the greater use of these techniques. Copyright © 2001 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Net Health Benefits: A New Framework for the Analysis of Uncertainty in Cost-Effectiveness Analysis
Stinnett, A. A., & Mullahy, J. (1998) · Medical Decision Making · doi:10.1177/0272989x98018002s09 · Cited by 1,102
Costs, effects and C/E‐ratios alongside a clinical trial
Van Hout, B. A., Al, M. J., Gordon, G. S., & Rutten, F. F. H. (1994) · Health Economics · doi:10.1002/hec.4730030505 · Cited by 964
Claxton, K. (1999) · Journal of Health Economics · doi:10.1016/s0167-6296(98)00039-3 · Cited by 889
Self-citationAn economic approach to clinical trial design and research priority-setting
Claxton, K., & Posnett, J. (1996) · Health Economics · doi:10.1002/(sici)1099-1050(199611)5:6<513::aid-hec237>3.0.co;2-9 · Cited by 395
Self-citationHandling uncertainty when performing economic evaluation of healthcare interventions.
Briggs, & Gray (1999) · Health Technology Assessment · doi:10.3310/hta3020 · Cited by 387
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · Cited by 302
Definition, interpretation and calculation of cost-effectiveness acceptability curves
L�thgren, M., & Zethraeus, N. (2000) · Health Economics · doi:10.1002/1099-1050(200010)9:7<623::aid-hec539>3.0.co;2-v · Cited by 292
On the decision rules of cost-effectiveness analysis
Johannesson, M., & Weinstein, M. C. (1993) · Journal of Health Economics · doi:10.1016/0167-6296(93)90005-y · Cited by 288
Cited by
A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy
Hajek, P., Phillips-Waller, A., Przulj, D., Pesola, F., Myers Smith, K., Bisal, N., Li, J., Parrott, S., Sasieni, P., Dawkins, L., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1808779 · Cited by 1,421
Manca, A., Hawkins, N., & Sculpher, M. J. (2005) · Health Economics · doi:10.1002/hec.944 · Cited by 1,024
Self-citationCost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions
Fenwick, E., O'Brien, B. J., & Briggs, A. (2004) · Health Economics · doi:10.1002/hec.903 · Cited by 943
Self-citationOutcomes for COPD pharmacological trials: from lung function to biomarkers
Cazzola, M., MacNee, W., Martinez, F. J., Rabe, K. F., Franciosi, L. G., Barnes, P. J., Brusasco, V., Burge, P. S., Calverley, P. M. A., Celli, B. R., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00099306 · Cited by 858
Ramsey, S. D., Willke, R. J., Glick, H., Reed, S. D., Augustovski, F., Jonsson, B., Briggs, A., & Sullivan, S. D. (2015) · Value in Health · doi:10.1016/j.jval.2015.02.001 · Cited by 811
Mindfulness-based cognitive therapy to prevent relapse in recurrent depression.
Kuyken, W., Byford, S., Taylor, R. S., Watkins, E., Holden, E., White, K., Barrett, B., Byng, R., Evans, A., Mullan, E., et al. (2008) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0013786 · Cited by 770
Assessing Evidence Inconsistency in Mixed Treatment Comparisons
Lu, G., & Ades, A. E. (2006) · Journal of the American Statistical Association · doi:10.1198/016214505000001302 · Cited by 756
Ramsey, S., Willke, R., Briggs, A., Brown, R., Buxton, M., Chawla, A., Cook, J., Glick, H., Liljas, B., Petitti, D., et al. (2005) · Value in Health · doi:10.1111/j.1524-4733.2005.00045.x · Cited by 720
UK BEAM Trial Team (2004) · BMJ · doi:10.1136/bmj.38282.669225.ae · Cited by 518
Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra
Claxton, K., Sculpher, M., McCabe, C., Briggs, A., Akehurst, R., Buxton, M., Brazier, J., & O'Hagan, T. (2005) · Health Economics · doi:10.1002/hec.985 · Cited by 472
Self-citationA guide to cost-effectiveness acceptability curves
Fenwick, E., & Byford, S. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.187.2.106 · Cited by 420
Self-citationMultiple regression of cost data: use of generalised linear models
Barber, J., & Thompson, S. (2004) · Journal of Health Services Research & Policy · doi:10.1258/1355819042250249 · Cited by 404
Hurley, M. V., Walsh, N. E., Mitchell, H., Nicholas, J., & Patel, A. (2012) · Arthritis Care & Research · doi:10.1002/acr.20642 · Cited by 407
Jones, J., Shepherd, J., Baxter, L., Gospodarevskaya, E., Hartwell, D., Harris, P., & Price, A. (2009) · Health Technology Assessment · doi:10.3310/hta13350 · Cited by 357
Cost-Effectiveness of Distributing Naloxone to Heroin Users for Lay Overdose Reversal
Coffin, P. O., & Sullivan, S. D. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-1-201301010-00003 · Cited by 343
Hewitt, C., Gilbody, S., Brealey, S., Paulden, M., Palmer, S., Mann, R., Green, J., Morrell, J., Barkham, M., Light, K., et al. (2009) · Health Technology Assessment · doi:10.3310/hta13360 · Cited by 330
Garry, R., Fountain, J., Brown, J., Manca, A., Mason, S., Sculpher, M., Napp, V, Bridgman, S., Gray, J., & Lilford, R. (2004) · Health Technology Assessment · doi:10.3310/hta8260 · Cited by 300
Self-citationCost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity
Hughes, D. A., Vilar, F. J., Ward, C. C., Alfirevic, A., Park, B. K., & Pirmohamed, M. (2004) · Pharmacogenetics · doi:10.1097/00008571-200406000-00002 · Cited by 290
Barton, G. R., Briggs, A. H., & Fenwick, E. A. L. (2008) · Value in Health · doi:10.1111/j.1524-4733.2008.00358.x · Cited by 290
Self-citationFenwick, E., Marshall, D. A., Levy, A. R., & Nichol, G. (2006) · BMC Health Services Research · doi:10.1186/1472-6963-6-52 · Cited by 279
Self-citationGoodyer, I. M., Reynolds, S., Barrett, B., Byford, S., Dubicka, B., Hill, J., Holland, F., Kelvin, R., Midgley, N., Roberts, C., et al. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30378-9 · Cited by 259
Claxton, K., Ginnelly, L., Sculpher, M., Philips, Z., & Palmer, S. (2004) · Health Technology Assessment · doi:10.3310/hta8310 · Cited by 258
Self-citationCoulton, S., Clift, S., Skingley, A., & Rodriguez, J. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.129908 · Cited by 255
McMillan, A., Bratton, D. J., Faria, R., Laskawiec-Szkonter, M., Griffin, S., Davies, R. J., Nunn, A. J., Stradling, J. R., Riha, R. L., & Morrell, M. J. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70172-9 · Cited by 234
Morrell, C. J., Sutcliffe, P., Booth, A., Stevens, J., Scope, A., Stevenson, M., Harvey, R., Bessey, A., Cantrell, A., Dennis, C.-L., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20370 · Cited by 155
Cost-effectiveness of psychological treatments for post-traumatic stress disorder in adults
Mavranezouli, I., Megnin-Viggars, O., Grey, N., Bhutani, G., Leach, J., Daly, C., Dias, S., Welton, N. J., Katona, C., El-Leithy, S., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0232245 · Cited by 115
Uncertainty and patient heterogeneity in medical decision models
Groot Koerkamp, B., Weinstein, M. C., Stijnen, T., Heijenbrok-Kal, M. H., & Hunink, M. G. M. (2010) · Medical Decision Making · doi:10.1177/0272989x09342277 · Cited by 105
Monahan, M., Jowett, S., Nickless, A., Franssen, M., Grant, S., Greenfield, S., Hobbs, F. D. R., Hodgkinson, J., Mant, J., & McManus, R. J. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12415 · Cited by 95
Drummond, C., Coulton, S., James, D., Godfrey, C., Parrott, S., Baxter, J., Ford, D., Lervy, B., Rollnick, S., Russell, I., et al. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.056697 · Cited by 93
Townsend, T., Blostein, F., Doan, T., Madson-Olson, S., Galecki, P., & Hutton, D. W. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.07.031 · Cited by 83
Hajek, P., Phillips-Waller, A., Przulj, D., Pesola, F., Smith, K. M., Bisal, N., Li, J., Parrott, S., Sasieni, P., Dawkins, L., et al. (2019) · Health Technology Assessment · doi:10.3310/hta23430 · Cited by 72
Legood, R., Gray, A., Wolstenholme, J., & Moss, S. (2006) · BMJ · doi:10.1136/bmj.38698.458866.7c · Cited by 68
Davidson, K., Tyrer, P., Gumley, A., Tata, P., Norrie, J., Palmer, S., Millar, H., Drummond, L., Seivewright, H., Murray, H., et al. (2006) · Journal of Personality Disorders · doi:10.1521/pedi.2006.20.5.431 · Cited by 67
Kimman, M. L., Dirksen, C. D., Voogd, A. C., Falger, P., Gijsen, B. C. M., Thuring, M., Lenssen, A., van der Ent, F., Verkeyn, J., Haekens, C., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.12.017 · Cited by 66
Ting, J., Tien Ho, P., Xiang, P., Sugay, A., Abdel-Sattar, M., & Wilson, L. (2015) · Value in Health · doi:10.1016/j.jval.2015.04.008 · Cited by 65
Cost-Effectiveness of Various Interventions for Newly Diagnosed Diabetic Macular Edema
Stein, J. D., Newman-Casey, P. A., Kim, D. D., Nwanyanwu, K. H., Johnson, M. W., & Hutton, D. W. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.02.002 · Cited by 65
Goodacre, S., Bradburn, M., Fitzgerald, P., Cross, E., Collinson, P., Gray, A., & Hall, A. (2011) · Health Technology Assessment · doi:10.3310/hta15230 · Cited by 64
Why it’s Time to Abandon the ICER
Paulden, M. (2020) · PharmacoEconomics · doi:10.1007/s40273-020-00915-5 · Cited by 65
Maguire, A., Clarkson, J. E., Douglas, G. V., Ryan, V., Homer, T., Marshman, Z., McColl, E., Wilson, N., Vale, L., Robertson, M., et al. (2020) · Health Technology Assessment · doi:10.3310/hta24010 · Cited by 55
Tyrer, P., Salkovskis, P., Tyrer, H., Wang, D., Crawford, M. J., Dupont, S., Cooper, S., Green, J., Murphy, D., Smith, G., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21500 · Cited by 59
“Cost-effectiveness acceptability curves (CEACs) were therefore constructed, and these show the likelihood that CBT is cost-effective for different values a decision-maker is willing to pay for improvements in outcome.(50) All analyses were adjusted for baseline costs and for baseline HAI and EQ-5D scores as appropriat…”
MethodStevenson, M., Scope, A., Sutcliffe, P., Booth, A., Slade, P., Parry, G., Saxon, D., & Kalthenthaler, E. (2010) · Health Technology Assessment · doi:10.3310/hta14440 · Cited by 57
Solomon, D., Proudfoot, J., Clarke, J., & Christensen, H. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.4207 · Cited by 55
“A decision that returns a positive NMB is considered to be cost-effective [48], and the optimal strategy is defined as the strategy with highest expected net benefit.”
Uyei, J., Fiellin, D. A., Buchelli, M., Rodriguez-Santana, R., & Braithwaite, R. S. (2017) · The Lancet Public Health · doi:10.1016/s2468-2667(17)30006-3 · Cited by 55
Kuyken, W., Byford, S., Byng, R., Dalgleish, T., Lewis, G., Taylor, R., Watkins, E. R., Hayes, R., Lanham, P., Kessler, D., et al. (2010) · Trials · doi:10.1186/1745-6215-11-99 · Cited by 48
Weatherly, H. L. A., Griffin, S. C., Mc Daid, C., Durée, K. H., Davies, R. J. O., Stradling, J. R., Westwood, M. E., & Sculpher, M. J. (2009) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462309090047 · Cited by 48
Self-citationLuciano, J. V., D’Amico, F., Cerdà-Lafont, M., Peñarrubia-María, M. T., Knapp, M., Cuesta-Vargas, A. I., Serrano-Blanco, A., & García-Campayo, J. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0451-y · Cited by 48
Watson, J., Crosby, H., Dale, V., Tober, G., Wu, Q., Lang, J., McGovern, R., Newbury-Birch, D., Parrott, S., Bland, J., et al. (2013) · Health Technol Assess · doi:10.3310/hta17250 · Cited by 47
Boyers, D., McNamee, P., Clarke, A., Jones, D., Martin, D., Schofield, P., & Smith, B. H. (2013) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e318250f539 · Cited by 46
Camacho, E. M., Ntais, D., Coventry, P., Bower, P., Lovell, K., Chew-Graham, C., Baguley, C., Gask, L., Dickens, C., & Davies, L. M. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012514 · Cited by 46
Howard, L., Flach, C., Leese, M., Byford, S., Killaspy, H., Cole, L., Lawlor, C., Betts, J., Sharac, J., Cutting, P., et al. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.081083 · Cited by 46
Zafar, S., Sikander, S., Hamdani, S. U., Atif, N., Akhtar, P., Nazir, H., Maselko, J., & Rahman, A. (2016) · Trials · doi:10.1186/s13063-016-1308-2 · Cited by 41
Tyrer, P., Cooper, S., Tyrer, H., Salkovskis, P., Crawford, M., Green, J., Smith, G., Reid, S., Dupont, S., Murphy, D., et al. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-99 · Cited by 31
Duarte, A., Walker, S., Littlewood, E., Brabyn, S., Hewitt, C., Gilbody, S., & Palmer, S. (2017) · Psychological Medicine · doi:10.1017/s0033291717000289 · Cited by 30
Bartels, S. L., Johnsson, S. I., Boersma, K., Flink, I., McCracken, L. M., Petersson, S., Christie, H. L., Feldman, I., Simons, L. E., Onghena, P., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-059152 · Cited by 23
Brown, J., James, K., Lisk, S., Shearer, J., Byford, S., Stallard, P., Deighton, J., Saunders, D., Yarrum, J., Fonagy, P., et al. (2024) · The Lancet Psychiatry · doi:10.1016/s2215-0366(24)00101-9 · Cited by 21
“33 All economic analyses were adjusted for baseline severity (MFQ score), aggregated level school deprivation, geographical area, school size, gender, and ethnicity group, plus the variable of interest (cost or QALYs).”
Metadata
- Authors
- Fenwick, E., Claxton, K., & Sculpher, M.
- Venue
- Health Economics
- Publisher
- Wiley
- Published
- 2001-07-20
- Volume
- 10
- Issue
- 8
- Pages
- 779-787
- ISSN
- 1057-9230 (ISSN-L)
- 1099-1050
- OpenAlex
- W2106203584
- Cited by
- 1,110
- References
- 18
- FWCI
- 48.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.